Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares KNSA
$76.06
-0.59%
at last close
Market Cap$5.93 billion
P/E Ratio—
Div Yield—
Volume219.8K
52-Week Range
$26.27$82.94
Key Stats
- Today's Range
- $75.52 – $77.82
- 50-Day Range
- $46.10 – $82.94
- 52-Week Range
- $26.27 – $82.94
- Volume
- 220K shs
- Average Volume
- 980K shs
- Market Cap
- $5.93 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.02%
- Days to Cover
- 1.00
About Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
Related Stocks
Compare head-to-head: KNSA vs LLY·KNSA vs JNJ·KNSA vs ABBV·KNSA vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.